The influence of oestradiol benzoate and progesterone treatment and of tolerance to relaxin on the uptake of I-labelled porcine relaxin by reproductive tissues was investigated in anaesthetized female rats. In ovary-intact rats, I-labelled relaxin uptake increased with time in reproductive tissues and in tissues concerned with metabolism and excretion.
Introduction
Relaxin is physiologically important during pregnancy in rats for inhibition of uterine contractions, softening of the cervix and a high incidence of live births (Downing and Sherwood, 1985a-c) . Uterine sensitivity to relaxin as an inhibitor of spon¬ taneous uterine contractions in nonpregnant rats in vivo is enhanced by oestradiol benzoate and progesterone treatment (Downing and Hollingsworth, 1992a, b) . Treatment with a physiological dose of oestradiol benzoate (0.4 pg kg-1 day-1) for 2 days produced a twofold increase and treatment with oestradiol benzoate plus progesterone produced an eightfold increase in uterine sensitivity to relaxin. Oestrogen pretreat¬ ment has also been shown to be necessary for relaxin to induce softening of the cervix and maximum effect of relaxin occurs after pretreatment with oestrogen plus progesterone (Kroc et al, 1959; Cullen and Harkness, 1960; Downing and Sherwood, 1985c, 1986) . Although there is little information concerning hormonal modulation of specific binding sites for relaxin it has been suggested that oestrogen increases the concentration of binding sites for relaxin in both the uterus and cervix (MercadoSimmen et al, 1982) . Osheroff et al. (1992) (Wiqvist, 1959; Downing and Hollingsworth, 1992a (Levitzki, 1986;  The mechanism by which relaxin inhibits uterine contractions is not fully known. Relaxin induces a moderate increase in myometrial concentrations of cAMP in the presence of phosphodiesterase inhibitors in vitro (Cheah and Sherwood, 1980;  Sanbom et al, 1980; Hsu et al, 1985) . However, relaxin induces only a very small increase in uterine cAMP concentrations in vivo (Downing et al, 1992) . Relaxin is antagonized in vivo by glibenclamide, which blocks ATP-sensitive potassium channels (Downing and Hollingsworth, 1991) , but such antagonism was not observed in vitro (Hughes et al, 1992) . Phentolamine, which blocks both a-adrenoceptors and ATP-sensitive potassium channels (Plant and Henquin, 1990) , also delays the onset of inhibition of uterine contractions in vivo by relaxin (Porter et al, 1979 s.c. postoperatively for analgesia. The animals were then treated with one of the following: corn oil (1 ml kg-1) s.c. daily for 1 (n = 5 rats) or 2 days (n = 5 rats); oestradiol benzoate (0.4 pg kg-1 in 1 ml corn oil kg-1) s.c. daily for 1 (n = 5 rats) or 2 days (n = 5 rats); oestradiol benzoate (40 pg kg-1 in 1 ml com oil kg-1) s.c. daily for 2 days (n = 9 rats); oestradiol benzoate (0.4 pg kg-1) plus progesterone (4 mg kg-1) s.c. in 1 ml com oil kg-1 daily for 1 (n = 5 rats) or 2 days (n = 5 rats). 
Results
Experiment A: determination of biological activity of Bolton-Hunter-labelled relaxin There were no significant differences in log ID50 values (porcine relaxin, 0.92 + 0.12 pg kg-1; Bolton-Hunter relaxin, 1.19 + 0.14 pg kg-1) or slopes of the regression lines for the dose-response curves (porcine relaxin, 45.8 + 10.9% pg"1 kg"1; Bolton-Hunter relaxin, 34.1 ± 6.0% pg"1 kg"1) (Fig. 1 Fig.   2a, b) . rats; 3 h with administration of 50 µg unlabelled relaxin just before injection of I25I-labelled relaxin (four rats), or relaxin at 20 µg kg-1 h"1 (3 h, five rats; 12 h, six rats) or 50 µg kg-1 h"1 (3 h, five rats; 12 h, six rats; 3 h with administration of 50 µg (five rats) or 100 µg (four rats) unlabelled relaxin just before injection of I25I-labelled relaxin). Histo¬ grams show means + SEM. Significant difference from saline-infused rats at appropriate time after cessation of infusion: *P < 0.01, *"P < 0.001.
for both uterus and cervix. At 3 h after termination of infusion of relaxin at 50 pg kg"1 h"1, uterine and cervical uptake of 125I-labelled relaxin was significantly reduced compared with uteri and cervices from saline infused rats (P < 0.02, < 0.01, respectively) and rats which received relaxin infusion at 20 pg kg"1 h"1 (P < 0.02, < 0.05, respectively, Fig. 3a, b) . By 12 h after termination of infusion, uterine and cervical uptake of 125I-labelled relaxin was similar in rats given an infusion of saline and in rats given an infusion of relaxin at 20 pg kg" h~or 50 pg kg"1 h"1. Administration of 50 pg or 100 pg unlabelled relaxin just before injection of 125I-labelled relaxin significantly reduced uterine and cervical 125I-labelled relaxin uptake in both saline-infused rats (P < 0.001) and in rats given an infusion of relaxin at 50 pg kg"1 h"1 (P < 0.01). 
